TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18507525

Group type: EXPERIMENTAL
Intervention: Needle-free injection device (NFID)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Needle/syringe (NS) followed by NFID
Number of subjects: 349
Study: 16609107

Group type: EXPERIMENTAL
Intervention: Laser-assisted anesthesia (Er:YAG unit, fluence 3.5 J/cm2, pulse width 600 microseconds, spot diameter 6 mm) with lidocaine 4% cream
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham laser with lidocaine 4% cream
Number of subjects: 61
Study: 14563743

Group type: EXPERIMENTAL
Intervention: Montelukast and fluticasone
Number of subjects: 1490

Group type: COMPARATOR
Intervention: Salmeterol and fluticasone
Number of subjects: 1490
Study: 10826853

Group type: EXPERIMENTAL
Intervention: tPA (0.25 mg/kg/day in 0.9% saline) for 3 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 32
Study: 8844349

Group type: EXPERIMENTAL
Intervention: 1.5% Hyaluronic Acid (HA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 100% Glycerin (Control)
Number of subjects: 11
Study: 1321186

Group type: EXPERIMENTAL
Intervention: Candoxatril 200 mg twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6721970

Group type: EXPERIMENTAL
Intervention: Enflurane (mean 0.24 MAC‐h) with 50% nitrous oxide in oxygen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Halothane (mean 0.23 MAC‐h) with 50% nitrous oxide in oxygen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enflurane or Halothane
Number of subjects: 28
Study: 29969907

Group type: EXPERIMENTAL
Intervention: Citalopram for the treatment of agitation
Number of subjects: 0
Study: 25675290

Group type: EXPERIMENTAL
Intervention: Oral cefuroxime axetil 500 mg dose, twice daily for 3 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Parenteral cefuroxime axetil 750 mg IV dose, single dose before placement
Number of subjects: 67
Study: 24680330

Group type: EXPERIMENTAL
Intervention: Systemic application of dexamethasone (DEX) 10 mg×3 d followed by 5 mg×4 d
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Topical injection of methylprednisolone sodium succinate 40 mg every three days
Number of subjects: 438

Group type: COMPARATOR
Intervention: Local corticosteroids injection in low‐middle frequencies
Number of subjects: 438
Study: 23770470

Group type: EXPERIMENTAL
Intervention: Individualized growth standard (IS)
Number of subjects: 1588

Group type: COMPARATOR
Intervention: Population standard (PS)
Number of subjects: 1588
Study: 21039759

Group type: EXPERIMENTAL
Intervention: Cannabis-based medicine (CBM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 18165444

Group type: EXPERIMENTAL
Intervention: Enteral glutamine 0.5 g/kg/d during the first 24 hours of resuscitation and 10 days thereafter
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group received isonitrogenous whey powder plus immune‐enhancing diet
Number of subjects: 20
Study: 16553675

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 15242433

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 20 micrograms/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 11408005

Group type: EXPERIMENTAL
Intervention: Lp(a) levels
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: apo(a) isoform size <= 22 KIV
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: TTTTA repeats >= 10
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Lp(a) levels with low apo(a) weight
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: (TTTTA)(n) polymorphism
Number of subjects: 360
Study: 9430085

Group type: EXPERIMENTAL
Intervention: Fatty-acid modified, cholesterol-reduced animal fat (FAMCRAF)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cholesterol-reduced animal fat (CRAF)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Unaltered animal fat (AF)
Number of subjects: 29
Study: 7962302

Group type: EXPERIMENTAL
Intervention: L-692,429 (0.2 mg/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: L-692,429 (0.75 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: GHRH (1 microgram/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: GHRH
Number of subjects: 16
Study: 2853764

Group type: EXPERIMENTAL
Intervention: metoprolol + terbutaline (10 mg/day + 200 mg/day)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: metoprolol (200 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: terbutaline (10 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: orciprenaline (30 mg/day)
Number of subjects: 45
Study: 29806667

Group type: EXPERIMENTAL
Intervention: Computer-guided group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Freehand group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 26657184

Group type: EXPERIMENTAL
Intervention: CMV glycoprotein B (gB) vaccine with MF59
Number of subjects: 402

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 402
Study: 24169014

Group type: EXPERIMENTAL
Intervention: Echocardiographically guided LV lead positioning
Number of subjects: 151

Group type: COMPARATOR
Intervention: Remote LV leads
Number of subjects: 151
Study: 22258366

Group type: EXPERIMENTAL
Intervention: Access to the Australian Cancer Trials web site
Number of subjects: 493

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 493
Study: 20052549

Group type: EXPERIMENTAL
Intervention: Spinach preparation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Perilla preparation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both vegetables
Number of subjects: 12
Study: 18780315

Group type: EXPERIMENTAL
Intervention: Cisplatin (20 mg/m²/day, Days 1-5) and Vinorelbine (6 mg/m² bolus on Day 1 and 6 mg/m²/day continuous infusion on Days 1-5) with concurrent 30-gray fractionated external-beam radiotherapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cisplatin and Vinorelbine with concurrent radiotherapy
Number of subjects: 25
Study: 15911360

Group type: EXPERIMENTAL
Intervention: Adjunctive lamotrigine therapy for 16 weeks
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Lamotrigine monotherapy for 12 weeks
Number of subjects: 547
Study: 12769163

Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril 10 mg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine 5-10 mg (1st step)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol 50-100 mg (2nd step)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 10654588

Group type: EXPERIMENTAL
Intervention: Phytosterol ester-enriched margarine (8.6 g vegetable oil phytosterols)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control margarine (40 g)
Number of subjects: 24
Study: 8712422

Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV) with size 2 laryngeal mask airway (LMA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Tracheal intubation (Control group)
Number of subjects: 46
Study: 1650023

Group type: EXPERIMENTAL
Intervention: Rapid Infusion System (RIS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional Fluid Administration (CFA)
Number of subjects: 36
Study: 6849742

Group type: EXPERIMENTAL
Intervention: Practolol 50 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Practolol 200 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol 10 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30621276

Group type: EXPERIMENTAL
Intervention: L-Valine 0.15 kcal/min (total: 3.3 g)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-Valine 0.45 kcal/min (total: 9.9 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 12
Study: 28881472

Group type: EXPERIMENTAL
Intervention: Domagrozumab 10 mg/kg IV (single dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Domagrozumab 10 mg/kg IV (multiple doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Domagrozumab (various doses IV and SC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Domagrozumab (various doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Domagrozumab 20 mg/kg IV
Number of subjects: 24
Study: 26847437

Group type: EXPERIMENTAL
Intervention: Sputum-based markers of speed of clearance of bacilli (time to smear negative status, time to culture negative status on LJ or in MGIT, daily rate of change of log10(TTP) to day 56)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference model adjusted for BMI, history of smoking, HIV status, cavitation, gender and MGIT TTP
Number of subjects: 0
Study: 25888092

Group type: EXPERIMENTAL
Intervention: 50 mg pethidine i.v.
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both groups (pethidine and placebo)
Number of subjects: 98
Study: 23094932

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy 1 h/week for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Supportive treatment for the same time period
Number of subjects: 90
Study: 20022457

Group type: EXPERIMENTAL
Intervention: Periarticular infiltration of corticosteroid, opioid, and a local anesthetic
Number of subjects: 40
Study: 18517074

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 16099715

Group type: EXPERIMENTAL
Intervention: 15mg sibutramine (SB) at bedtime for 1 month
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PL) at bedtime for 1 month
Number of subjects: 21
Study: 12453973

Group type: EXPERIMENTAL
Intervention: Inhaled regular insulin (INH) via Aerodose Insulin Inhaler, 240 units
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Inhaled regular insulin (INH)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Subcutaneously injected regular insulin (SC)
Number of subjects: 15
Study: 10624751

Group type: EXPERIMENTAL
Intervention: Mouth taped closed
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ventilator-induced awake hypopharyngeal pressure swing during timed bilevel ventilation
Number of subjects: 9
Study: 7586605

Group type: EXPERIMENTAL
Intervention: GHRH1-29NH2 (1 microgram/kg BW)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GHRP-2 (1 microgram/kg BW)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined GHRH1-29NH2 and GHRP-2 (1 microgram/kg BW each)
Number of subjects: 8
Study: 1771378

Group type: EXPERIMENTAL
Intervention: Mucin-containing saliva substitute
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose (CMC)-containing saliva substitute
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study: 6721668

Group type: EXPERIMENTAL
Intervention: Individual psychotherapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Conjoint psychotherapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 64
Study: 30234528

Group type: EXPERIMENTAL
Intervention: Ultrasound group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Landmark group
Number of subjects: 80
Study: 30646314

Group type: EXPERIMENTAL
Intervention: Levocarnitine (18 g)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Levocarnitine (12 g)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Levocarnitine (6 g)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 250
Study: 27894328

Group type: EXPERIMENTAL
Intervention: Driving pressure (ΔPrs)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Plateau pressure (Pplat,rs)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Compliance (Crs)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Tidal volume (VT)
Number of subjects: 787
Study: 24498404

Group type: EXPERIMENTAL
Intervention: School-based physical activity program (KISS) including daily physical education (two additional lessons per week), short physical activity breaks, and daily physical activity homework.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 502
Study: 22625433

Group type: EXPERIMENTAL
Intervention: Dorsiflexion ankle orthosis during the 6-minute walk test (6MWT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6-minute walk test (6MWT) without the dorsiflexion ankle orthosis
Number of subjects: 40
Study: 20067609

Group type: EXPERIMENTAL
Intervention: Losartan treatment
Number of subjects: 330
Study: 21945258

Group type: EXPERIMENTAL
Intervention: 15 μg of hemagglutinin antigen without adjuvant
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 7.5 μg of hemagglutinin antigen with aluminum hydroxide, MPL and squalene
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 3.75 μg of hemagglutinin antigen with aluminum hydroxide and MPL
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 3.75 μg of hemagglutinin antigen with aluminum hydroxide and squalene
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 266
Study: 16139656

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg/day
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Gabapentin 900 mg/day
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study: 11896424

Group type: EXPERIMENTAL
Intervention: DHAP regimen
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CPM) 5 g/m(2)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall mobilization chemotherapy regimens (DHAP or CPM)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: DHAP
Number of subjects: 72
Study: 9588637

Group type: EXPERIMENTAL
Intervention: Salbutamol via jet nebuliser (JN)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Salbutamol via pressurised metered dose inhaler (PMDI)
Number of subjects: 160
Study: 7905937

Group type: EXPERIMENTAL
Intervention: Sevoflurane 2%
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sevoflurane 3%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sevoflurane 0%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sevoflurane 1%
Number of subjects: 37
Study: 3178370

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride
Number of subjects: 340

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 340

Group type: COMPARATOR
Intervention: Bendroflumethiazide
Number of subjects: 340
Study: 28624918

Group type: EXPERIMENTAL
Intervention: Dim lighting with light instrumental music (modified group, 30 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No music and standard lighting (standard group, 30 patients)
Number of subjects: 60
Study: 26942657

Group type: EXPERIMENTAL
Intervention: Cold Shower (CS) at 20.8°C ± 0.80°C for 15 minutes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Cold Shower (CS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (CON) condition (seated in the chamber for 15 minutes)
Number of subjects: 17
Study: 25903450

Group type: EXPERIMENTAL
Intervention: Monitored program of ≥150 min of moderate- to vigorous-intensity physical activity per week for 6 months
Number of subjects: 41
Study: 23065350

Group type: EXPERIMENTAL
Intervention: Coping Power
Number of subjects: 245
Study: 20356487

Group type: EXPERIMENTAL
Intervention: Moxifloxacin-based triple therapy (rabeprazole 10 mg twice a day, moxifloxacin 400 mg/day, amoxicillin 1000 mg twice a day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Bismuth-based quadruple therapy (rabeprazole 10 mg twice a day, bismuth salts 150 mg three times a day, clarithromycin 500 mg twice a day, metronidazole 400 mg twice a day)
Number of subjects: 109
Study: 18055472

Group type: EXPERIMENTAL
Intervention: Abatacept (approximately 10 mg/kg every 4 weeks)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Infliximab (3 mg/kg every 8 weeks)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo (every 4 weeks)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 431
Study: 16035956

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 12514674

Group type: EXPERIMENTAL
Intervention: Vitamin C infusion with furosemide
Number of subjects: 27

Group type: COMPARATOR
Intervention: Furosemide alone
Number of subjects: 27

Group type: COMPARATOR
Intervention: Furosemide with placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Furosemide with vitamin C and kallikrein inhibitor (nafamostat mesilate)
Number of subjects: 27
Study: 10826586

Group type: EXPERIMENTAL
Intervention: Local anaesthetic spray
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 9015941

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 27
Study: 1740599

Group type: EXPERIMENTAL
Intervention: Education program + support group (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Education program (Group B)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 32
Study: 6541512

Group type: EXPERIMENTAL
Intervention: Enteric-coated granules (EG)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Conventional enteric-coated tablet (ET)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional aspirin (control)
Number of subjects: 12
Study: 31096259

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (CH)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Resin‐modified GIC (RMGIC)
Number of subjects: 198

Group type: COMPARATOR
Intervention: No liner (DC)
Number of subjects: 198
Study: 29948188

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (escitalopram)
Number of subjects: 38
Study: 26578117

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 90
Study: 25181575

Group type: EXPERIMENTAL
Intervention: 1000 μg of phylloquinone daily for 12 months (with Ca 500 mg/d and vitamin D3 10 μg/d)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (with Ca 500 mg/d and vitamin D3 10 μg/d)
Number of subjects: 43
Study: 23700589

Group type: EXPERIMENTAL
Intervention: Computer-assisted learning (CAL) module
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional text-/image-based learning supplements
Number of subjects: 0
Study: 20506534

Group type: EXPERIMENTAL
Intervention: Severe OA group
Number of subjects: 95

Group type: COMPARATOR
Intervention: Asymptomatic group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 95
Study: 17963865

Group type: EXPERIMENTAL
Intervention: Diaphragm with 6% CS gel
Number of subjects: 119

Group type: COMPARATOR
Intervention: Diaphragm with KY gel
Number of subjects: 119

Group type: COMPARATOR
Intervention: CS gel alone
Number of subjects: 119
Study: 15987488

Group type: EXPERIMENTAL
Intervention: prednisolone
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 11983451

Group type: EXPERIMENTAL
Intervention: Daily interferon alfa-2b (3 million units per day for 12 weeks then 3 million units three times per week for 24 weeks) and ribavirin (36 week treatment)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b three times a week (alone or in combination with ribavirin)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Interferon alfa-2b alone
Number of subjects: 321
Study: 9802051

Group type: EXPERIMENTAL
Intervention: Music intervention during high-dose chemotherapy (48 hours of high-dose cyclophosphamide)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual antiemetic protocol (control group)
Number of subjects: 33
Study: 7706152

Group type: EXPERIMENTAL
Intervention: Voice output communication aid (VOCA)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Traditional staff management programs
Number of subjects: 1
Study: 2545454

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 mg day‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg day‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of Hydrochlorothiazide and Enalapril
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 20
Study: 200435

Group type: EXPERIMENTAL
Intervention: Fosazepam 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31512716

Group type: EXPERIMENTAL
Intervention: Sevoflurane-based anaesthetic regimen (1-3% sevoflurane inhalation during anaesthesia maintenance)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Propofol-based anaesthetic regimen (6-10 mg/kg/h propofol infusion during anaesthesia maintenance)
Number of subjects: 42
Study: 30497087

Group type: EXPERIMENTAL
Intervention: FVL echoendoscope
Number of subjects: 126

Group type: COMPARATOR
Intervention: CLA echoendoscope
Number of subjects: 126
Study: 28664557

Group type: EXPERIMENTAL
Intervention: Oxygen therapy (O2)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 87
Study: 24931823

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 24498845

Group type: EXPERIMENTAL
Intervention: Chelladaghi herbal extract (suppository) administered every 12 hours from 24 hours before to 24 hours after surgery.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Chelladaghi herbal extract (oral) administered from 24 hours before to 24 hours after surgery.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo administered from 24 hours before to 24 hours after surgery.
Number of subjects: 90